iOmx Therapeutics
GermanyEntry
2021
Hold
5yr
Status
Active
Who owns iOmx Therapeutics?
iOmx Therapeutics is currently owned by MIG Capital through MIG Fonds 16 (2019 vintage), since 2021. Across its history, iOmx Therapeutics has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
MIG CapitalMIG Fonds 16 · 2019 · Evergreen
4 ownership periods · full history below
Key facts
Key takeaways
- ·Co-held by Wellington Partners, Sofinnova Partners, Athos and MIG Capital since 2016.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2016 · present
Wellington PartnersActive
2016 · present(10yr) · Wellington Partners Life Sciences · 1998 · VC
Sofinnova PartnersActive
2018 · present(8yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
MIG CapitalActive
2021 · present(5yr) · MIG Fonds 16 · 2019 · Evergreen
AthosActive
2021 · present(5yr) · Athos Evergreen Life Sciences · 2001 · Evergreen
More from MIG Fonds 16
Other portfolio companies in the same fund.
France
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
Track iOmx Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on iOmx Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue